Search Results - "Padro T"

HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression.

Authors: Martinez, G. Giron Padro, T. Guala, A. et al.

Source: Cardiovascular Research. 2026 Supplement, Vol. 122, pi86-i86. 1p.

This result is not displayed to guests.
Login for full access.

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.

Authors: Padro, T. Bieker, R. Ruiz, S. et al.

Source: Leukemia (08876924). Jul2002, Vol. 16 Issue 7, p1302. 9p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis.

Authors: Escate, R. Padro, T. Badimon, L.

Source: Atherosclerosis (00219150). Mar2016, Vol. 246, p177-186. 10p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

MiR-6821-5p and coronary calcification in familial hypercholesterolemia patients with subclinical atherosclerosis.

Authors: Padro, T Escate, R Suades, R et al.

Source: Cardiovascular Research. 2022 Supplement, Vol. 118, p1-1. 1p.

Adipsin a regulatory protein found in the extracellular matrix is modulated by hypercholesterolemia in myocardial infarction.

Authors: Padro, T Garcia-Arguinzonis, M Vilahur, G et al.

Source: Cardiovascular Research. 2022 Supplement, Vol. 118, p1-1. 1p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

P563Relevance of C3-complement activation in atherosclerotic plaques and in the lipid-loaded smooth muscle cell phenotype.

Authors: Padro, T Garcia-Arguinzonis, M Diaz, E et al.

Source: Cardiovascular Research. 2018 Supplement, Vol. 114, pS138-S138. 1p.

525 Distinctive miRNA signature associated to inflammation in monocytes exposed to atherogenic low density lipoproteins: miR126.

Authors: Escate, R Padro, T Badimon, L

Source: Cardiovascular Research. Jul2014, Vol. 103 Issue suppl_1, pS96-S96. 1p.

P64 Exosomal microRNA signature predicts future ischemic events in hypercholesterolemic patients.

Authors: Suades, R Padro, T Alonso, R et al.

Source: Cardiovascular Research. Jul2014, Vol. 103 Issue suppl_1, pS10-S10. 1p.

WO4-OR-6 LOW-DENSITY LIPOPROTEINS NEGATIVELY REGULATE HSP 27 PHOSPHORYLATION IN VASCULAR SMOOTH MUSCLE CELLS

Authors: Garcia Arguinzonis, M.I. Padro, T. Llorente-Cortes, V. et al.

Source: Atherosclerosis (Supplements). Jun2007, Vol. 8 Issue 1, p5-5. 1p.

MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis.

Authors: Escate Chavez, R. E. Perez De Isla, L. P. Casanas, M. C. et al.

Source: Cardiovascular Research. 2026 Supplement, Vol. 122, pi2-i2. 1p.

HDL adverse remodelling and dysfunction is a temporal feature that can be reversed.

Authors: Schoch, L Sutelman, P Padro, T et al.

Source: Cardiovascular Research. 2022 Supplement, Vol. 118, p1-1. 1p.

Mitochondrial proteomic response to post-conditioning: a network-assisted systems biology analysis in a preclinical model.

Authors: Gallinat, A Vilahur, G Padro, T et al.

Source: Cardiovascular Research. 2022 Supplement, Vol. 118, p1-1. 1p.